Tirzepatide, Liraglutide, and Semaglutide are the only three GLP-1 weight-control drugs currently approved by the FDA. According to JP Morgan Research, obesity and diabetes will drive the GLP-1 ...

We recently published a list of 10 Best Weight Loss Drug Stocks to Buy According to Analysts. In this article, we are going to take a look at where GSK plc (NYSE ... GLP-1 weight-control drugs ...